American Century Companies’s Genmab GMAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.5M Buy
599,953
+61,009
+11% +$1.62M 0.01% 1379
2026
Q1
$14.5M Buy
538,944
+107,392
+25% +$3.22M 0.01% 1317
2025
Q4
$13.3M Buy
431,552
+59,499
+16% +$1.85M 0.01% 1328
2025
Q3
$11.4M Buy
372,053
+63,616
+21% +$1.55M 0.01% 1377
2025
Q2
$6.37M Sell
308,437
-75,454
-20% -$1.55M ﹤0.01% 1561
2025
Q1
$7.52M Buy
383,891
+63,316
+20% +$1.33M ﹤0.01% 1427
2024
Q4
$6.69M Sell
320,575
-76,505
-19% -$1.68M ﹤0.01% 1490
2024
Q3
$9.68M Sell
397,080
-55,115
-12% -$1.47M 0.01% 1322
2024
Q2
$11.4M Sell
452,195
-12,747
-3% -$361K 0.01% 1193
2024
Q1
$13.9M Buy
464,942
+8,520
+2% +$250K 0.01% 1071
2023
Q4
$14.5M Buy
456,422
+5,914
+1% +$186K 0.01% 990
2023
Q3
$15.9M Sell
450,508
-9,028
-2% -$344K 0.01% 884
2023
Q2
$17.5M Sell
459,536
-158,052
-26% -$6.3M 0.01% 825
2023
Q1
$23.3M Buy
617,588
+7,209
+1% +$277K 0.02% 684
2022
Q4
$25.9M Buy
610,379
+16,569
+3% +$683K 0.02% 634
2022
Q3
$19.1M Sell
593,810
-9,340
-2% -$328K 0.02% 676
2022
Q2
$19.6M Buy
603,150
+182,311
+43% +$5.91M 0.02% 671
2022
Q1
$15.2M Buy
420,839
+381,013
+957% +$13.1M 0.01% 774
2021
Q4
$1.58M Buy
39,826
+1,424
+4% +$59.4K ﹤0.01% 1459
2021
Q3
$1.68M Buy
38,402
+9,006
+31% +$404K ﹤0.01% 1383
2021
Q2
$1.2M Buy
29,396
+640
+2% +$24.7K ﹤0.01% 1466
2021
Q1
$944K Buy
28,756
+8,683
+43% +$327K ﹤0.01% 1457
2020
Q4
$816K Buy
20,073
+7,295
+57% +$273K ﹤0.01% 1341
2020
Q3
$468K Buy
12,778
+324
+3% +$11.7K ﹤0.01% 1366
2020
Q2
$422K Buy
+12,454
New +$339K ﹤0.01% 1336

Other funds holding GMAB

American Century Companies's GMAB Position: Q2 2026 in Review

American Century Companies increased its Genmab (GMAB) stake by 11% in Q2 2026, buying an estimated $1.62M and bringing the position to 599,953 shares worth $16.5M. The position accounts for 0.01% of the portfolio, ranked #1379.

American Century Companies first reported a position in GMAB in Q2 2020 and has held it in 25 quarters since. The position peaked at $25.9M in Q4 2022. 290 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • American Century Companies held 599,953 shares of Genmab worth $16.5M as of Q2 2026.
  • American Century Companies bought 61,009 Genmab shares in Q2 2026, an estimated $1.62M.
  • Genmab made up 0.01% of American Century Companies's portfolio in Q2 2026, its #1379 holding.
  • American Century Companies first reported a position in Genmab in Q2 2020 and has held it in 25 quarters since.
  • American Century Companies's Genmab position peaked at $25.9M in Q4 2022.
  • 290 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.